Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. - Wikidata - awgldk - TriplyDB

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.

http://www.wikidata.org/entity/Q38002494

about

Immune response, safety, and survival and quality of life outcomes for advanced colorectal cancer patients treated with dendritic cell vaccine and cytokine-induced killer cell therapy Adoptive immunotherapy against ovarian cancer Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition Overcoming tumor immune evasion with an unique arbovirus Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.Dendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells.Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer.5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells.Pathogen-driven cancers and emerging immune therapeutic strategies.Arming cytokine-induced killer cells with chimeric antigen receptors: CD28 outperforms combined CD28-OX40 "super-stimulation".Human leukocyte antigen-haploidentical donor-derived cytokine-induced killer cells are safe and prolong the survival of patients with advanced non-small cell lung cancer.Effects of MICA expression on the prognosis of advanced non-small cell lung cancer and the efficacy of CIK therapy A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma Immunotherapy for hepatocellular carcinoma: From basic research to clinical use.Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy.Effect of inhibition proliferation in human lung adenocarcinoma A549 cells by cytokine-induced killer cells.Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy.Cord blood-derived cytokine-induced killer cellular therapy plus radiation therapy for esophageal cancer: a case report Meta-analysis of chemotherapy and dendritic cells with cytokine-induced killer cells in the treatment of non-small-cell lung cancer Cytokine-induced killer cell therapy for advanced pancreatic adenocarcinoma: A case report and review of the literature Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma.Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.Cell-based immunotherapy against gliomas: from bench to bedside In vitro-activated tumor-specific T lymphocytes prolong the survival of patients with advanced gastric cancer: a retrospective cohort study Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells.Cholangiocarcinoma-derived exosomes inhibit the antitumor activity of cytokine-induced killer cells by down-regulating the secretion of tumor necrosis factor-α and perforin.Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in Korea Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis.Engineering antiphagocytic biomimetic drug carriers.Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects.Adoptive immunotherapy against sarcomas.Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.Role of NKG2D in cytokine-induced killer cells against lung cancer.Immune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blasts.Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis.CD56 in the Immune System: More Than a Marker for Cytotoxicity?Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application.West African Sorghum bicolor leaf sheaths have anti-inflammatory and immune-modulating properties in vitro.

P2860

Q21284687-2C59E638-D69B-4071-810D-C1416C3386CE Q26748905-390F79B5-8282-4FA0-8513-72C90E9F343E Q27311035-4876BC01-4AA4-45BC-8B40-C425F6656DEF Q28081774-56800384-A3D8-467A-981B-67975C91D8A4 Q31157425-06EAB646-35D6-4BBC-9E60-474BD5F4D639 Q31157715-E6D6E4B7-E6CA-45E3-9910-A7E141CAA41E Q33415850-9A92E2A9-18AC-4084-8588-D347BC1C670D Q33884816-ED4EF68B-A2C9-46E2-B0D5-1D6FB2008458 Q34054175-0BCA559B-1999-4EC3-8E3F-B93A372E2C44 Q34367252-72B060A0-8284-477D-B45A-ED9B6EC25E87 Q34427336-A458B213-2647-4A39-AB87-1A5D1847A826 Q34918975-A34C4AE4-49D9-46C4-A599-C846385BB2C0 Q35182896-682EE033-B090-4DEE-8479-BBA48C3CB4A8 Q35567765-43279B0F-6D8C-4711-8A9E-50122E64F0E1 Q35870886-12AA2EE5-4843-4D09-872A-A17A1291D8AC Q35879402-5D5B50CB-0EDE-48B0-B64F-D411AC4C34E4 Q36060352-C11E2319-FC4B-454E-BF25-B857C31E91C1 Q36123941-CE1C0975-2118-47F6-86E5-DAED10A79FD5 Q36153869-A53426E1-484A-485A-94B5-68851AD6A00A Q36183714-D13C5F6A-C08B-44C9-804E-75A42A0E85C0 Q36774574-E751C6E8-47FA-4E31-B088-6E2A33D21AAE Q36865132-4E06011F-2AA4-45FE-A2E7-440056596692 Q36962962-71B61C04-DD37-4494-847D-16D55F0B42E5 Q36984482-E567C528-9113-4BC8-9D8D-5BB1AFE244C1 Q37042451-CE87981E-7BCE-4221-81AE-776DE67C662E Q37084335-A4F1F54C-BE44-48EA-80F5-42A86A8E642D Q37084575-DFF1BFC6-21A7-47DB-B911-889ECA02B8C6 Q37701716-FD1FD3FC-28DD-467D-95EE-850E06A141ED Q37718809-DA4CDC96-17DB-4512-B1D6-50AE1CB4C8CD Q38123856-BD4DE65C-E1F3-4BD1-AB22-1A629634AE01 Q38212354-8540D9B3-59A9-4FFD-9BE2-41D5FD49801C Q38231581-7217151F-BAE6-4C9F-909A-418F0E5A9EB9 Q38291193-805E0EA4-442A-47AE-B711-8511D0CBD79A Q38574526-CE98237D-D5C5-4BAD-8B93-99BAB5E9A2D5 Q38772095-3F1633AC-2828-45E5-9A7D-713092FFFABA Q38787535-429B375A-0EF5-4FF5-BEBF-9C970AA4969F Q39149552-A58A6C16-4E3D-4784-94FF-EB3F7502C729 Q40101148-1570AB21-D07E-49CA-BE34-98688CC0022A Q40289330-6FCA1E2C-1A6D-4FD1-AA67-E8C53137B891 Q41093902-C2BFA2B9-D112-4B6A-BEB5-693FBC3B7C6C

P2860

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.

http://www.wikidata.org/entity/Q38002494

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cytokine-induced killer (CIK) ...... the treatment of solid tumors.

@en

type

label

Cytokine-induced killer (CIK) ...... the treatment of solid tumors.

@en

prefLabel

Cytokine-induced killer (CIK) ...... the treatment of solid tumors.

@en

P1433

Q38002494-EAE3B37E-7701-4680-B5C3-F20FC7A5772F

P1476

Q38002494-459D3DA9-98B8-415D-905A-046E3AF1934F

P2093

Q38002494-518E9805-248D-4268-9EE7-E00E322DF54C

Q38002494-967BF3E8-57CD-4C6B-84C0-664EA7979102

Q38002494-99A44A9C-0E99-4FA4-A517-F2671B7C5109

Q38002494-AC5D4D16-F2DF-411A-9EC9-A3F84BB5D903

Q38002494-B0FD96A5-E769-4AE8-9302-93D3A7FF857C

Q38002494-B71AC631-4265-44F1-8FC7-1D11C2BAC03E

Q38002494-DA26D04E-75EC-44F1-9C4E-36FA7FA17B1A

P2860

Q38002494-09F2F645-F3D1-4CFA-AFEF-5FF58AEDFB65

Q38002494-0AF6B012-9ED9-40A9-85B1-C33EB33238E0

Q38002494-1375793E-073B-46D8-8013-8990B59BA433

Q38002494-15FCF6C2-177E-4E15-B4CB-19334769E3E6

Q38002494-18A534F9-4E64-48D9-B9FC-3BBB014931C9

Q38002494-1AD6B35C-EEE2-4A7C-868B-381CB80ACB0E

Q38002494-1DA4A20D-DBC9-4EEE-8114-ACC4D093D1E5

Q38002494-1F14A3F3-B05B-4722-95A2-83DE2C3912FB

Q38002494-1FD8E36A-4598-4583-BC10-0874C1711968

Q38002494-20DA4E67-7DA3-4170-8773-E2A6979680D5

P304

Q38002494-6858D95B-854C-45A6-AABA-5EC31C61D3DC

P31

Q38002494-6ACCC908-E0B9-4A3D-885A-3F38319D9768

P356

Q38002494-5F34A44F-8445-4521-86FF-ECE79BA262F4

P407

Q38002494-B60D53B3-9499-432E-AF2D-86681F664D2D

P433

Q38002494-22345D11-A934-4B24-AA68-5C69D1665229

P478

Q38002494-0EE81ECD-A4D6-4305-8748-556F0D30A2C1

P50

Q38002494-46E57F76-4797-4184-9A19-BBFBC3129F34

Q38002494-B94D1589-6021-4CDF-82B2-2F39849BC203

Q38002494-EE60C851-59FB-48AB-A97F-528C05B3BBF2

P577

Q38002494-E4712012-46F2-4F63-9CD4-DEA3D9D37317

P698

Q38002494-8FCA7634-520C-44B6-B092-CB4FA625E2C2

P921

Q38002494-FCA5FFF2-15A7-4625-B9C6-1D5EA8C6C8FF

P356

14712598.2012.675323

P1433

Expert Opinion on Biological Therapy

P1476

Cytokine-induced killer (CIK) ...... the treatment of solid tumors

@en

P2093

Fabrizio Carnevale-Schianca

http://www.w3.org/2001/XMLSchema#string

Giulia Mesiano

http://www.w3.org/2001/XMLSchema#string

Lidia Giraudo Diego

http://www.w3.org/2001/XMLSchema#string

Loretta Gammaitoni

http://www.w3.org/2001/XMLSchema#string

Maja Todorovic

http://www.w3.org/2001/XMLSchema#string

Valeria Leuci

http://www.w3.org/2001/XMLSchema#string

Wanda Piacibello

http://www.w3.org/2001/XMLSchema#string

P2860

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells

Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Cytokine-induced NK-like T cells: from bench to bedside.

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.

Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial.

P304

673-684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2012.675323

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22500889

http://www.w3.org/2001/XMLSchema#string

P921